-
1 Comment
KPC Pharmaceuticals, Inc is currently in a long term uptrend where the price is trading 13.9% above its 200 day moving average.
From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
KPC Pharmaceuticals, Inc's total revenue sank by 2.6% to $2B since the same quarter in the previous year.
Its net income has increased by 12.0% to $106M since the same quarter in the previous year.
Finally, its free cash flow grew by 131.7% to $216M since the same quarter in the previous year.
Based on the above factors, KPC Pharmaceuticals, Inc gets an overall score of 4/5.
| Exchange | SHG |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| ISIN | CNE0000015P8 |
| CurrencyCode | CNY |
| Market Cap | 13B |
|---|---|
| PE Ratio | 20.56 |
| Target Price | 23.77 |
| Beta | 0.17 |
| Dividend Yield | None |
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotic, immunosuppressive, and others. The company provides medicine and food, skin care, oral care, private care, and time-honored food series; and other products, such as oral medication and injections. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600422.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
